SCHEMBL23673265

SCHEMBL23673265

CC(C)(C)NS(=O)(=O)c1cccn1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
BRD4 O60885 2/20 0.42
BRD2 P25440 1/20 0.42
BRD3 Q15059 1/20 0.42
BRDT Q58F21 1/20 0.42
DUT P33316 1/20 0.41
SCN3A Q9NY46 1/20 0.41
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ADRA1D P25100 1/20 0.38
PKM P14618 1/20 0.37
NOTUM Q6P988 1/20 0.37
NSD2 O96028 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23113070 0.75 NOTUM (0.46) ALDH1A1BRD4BRD2BRD3BRDT
SCHEMBL25119665 0.74 HDAC8 (0.45) ALDH1A1BRD4BRD2BRD3BRDT
SCHEMBL22535064 0.74 HDAC8 (0.41) ALDH1A1BRD4BRD2BRD3BRDT
SCHEMBL8528623 0.73 MAPT (0.43) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL23113030 0.72 CA12 (0.49) ALDH1A1DUTMEN1KMT2AKDM4E
SCHEMBL23113075 0.71 CRHBP (0.49) ALDH1A1BRD4BRD2BRD3BRDT
SCHEMBL13492176 0.67 HDAC8 (0.47) ALDH1A1BRD4BRD2BRD3BRDT
SCHEMBL349527 0.66 MAPT (0.66) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL2803354 0.65 NSD2 (0.58) ALDH1A1MEN1KMT2AKDM4EMAPT
SCHEMBL634086 0.65 CA1 (0.57) ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11459296-B2 Antibacterial compounds Infex Therapeutics Limited (GB) 2022-10-04 US disclosed
US-20210230115-A1 Antibacterial Compounds Infex Therapeutics Limited (GB) 2021-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210230115-A1 Antibacterial Compounds GAA, MGAM, NQO1 ALDH1A1 291/4885BRD4 2163/4885BRD2 4105/4885
US-11459296-B2 Antibacterial compounds GAA, MGAM, NQO1 ALDH1A1 291/4885BRD4 2163/4885BRD2 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.